Median levels of ANG, ANGST, 8-iso-PGF2α, SNCG, and IL-13 were 7.7-fold, 6.3-fold, 1.5-fold, 1.3-fold, and 1.7-fold higher, respectively, in the NMIBC subgroup of BC patients compared with the control group. The gene discussed is IL13; the disease is breast cancer.